Exploration Capital Fund, LP - Dec 4, 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role
10%+ Owner
Signature
Stephen L. Gustin on behalf of Exploration Capital Fund, LP
Stock symbol
FRTX
Transactions as of
Dec 4, 2023
Transactions value $
-$26,362
Form type
4
Date filed
12/6/2023, 09:45 PM
Previous filing
Dec 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase -$6.44K -7.58K -1.11% $0.85 678K Dec 4, 2023 Direct F1, F2
transaction FRTX Common Stock Purchase -$4.41K -5.19K -0.75% $0.85 683K Dec 5, 2023 Direct F1, F2
transaction FRTX Common Stock Purchase -$15.5K -17.2K -2.4% $0.90 700K Dec 6, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
F2 Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.